Related Experiment Video
Updated: Jan 31, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
Renin-angiotensin system is an important factor in hormone refractory prostate cancer
Hiroji Uemura1, Hisashi Hasumi, Hitoshi Ishiguro
1Department of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Japan. hu0428@med.yokohama-cu.ac.jp
Background:
The aim of this study was to perform a comprehensive evaluation of the renin-angiotensin system (RAS) in prostate cancer.
Methods:
We investigated the expression of RAS components in prostate cancer cells treated with hormonal agents. Real-time PCR data showed the expression of the AT1 receptor, angiotensin I converting enzyme (ACE), and angiotensin I/II (Ang-I/II) precursor in all 87 prostate tissue samples.
Results:
Expression of these genes in hormone refractory prostate cancer (HRPC) was significantly higher than that in normal prostate tissue and untreated prostate cancer tissue. Western blot showed that protein expression of the AT1 receptor and Ang-I/II was enhanced in LNCaP cells cultivated in steroid-free medium. When LNCaP cells were stimulated with dihydrotestosterone (DHT), estradiol (E2), dexamethasone (DEX), or anti-androgen drugs, protein expression of the AT1 receptor and Ang-I/II was augmented.
Conclusions:
The present data suggest that prostatic RAS is overexpressed in HRPC tissue, and expression of its components is influenced by several kinds of hormonal stimulation.
Insights
The renin-angiotensin system (RAS) is overexpressed in hormone-refractory prostate cancer (HRPC). Hormonal stimulation influences the expression of RAS components in prostate cancer, suggesting a role in disease progression.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- The renin-angiotensin system (RAS) plays a role in various physiological processes.
- Prostate cancer is a significant health concern, and its underlying molecular mechanisms require further elucidation.
Purpose of the Study:
- To comprehensively evaluate the renin-angiotensin system (RAS) in prostate cancer.
- To investigate the expression of RAS components in prostate cancer cells under hormonal influence.
Main Methods:
- Real-time PCR was used to analyze the expression of RAS components (AT1 receptor, ACE, Ang-I/II precursor) in 87 prostate tissue samples.
- Western blot analysis assessed protein expression of the AT1 receptor and Ang-I/II in LNCaP cells under varying hormonal conditions (steroid-free medium, DHT, E2, DEX, anti-androgen drugs).
Main Results:
- RAS components were detected in all prostate tissue samples.
- Gene expression of AT1 receptor, ACE, and Ang-I/II precursor was significantly higher in hormone-refractory prostate cancer (HRPC) compared to normal and untreated prostate cancer tissues.
- Protein expression of the AT1 receptor and Ang-I/II was upregulated in LNCaP cells cultured in steroid-free medium and further augmented upon stimulation with androgens, estrogens, glucocorticoids, and anti-androgen drugs.
Conclusions:
- Prostatic RAS is overexpressed in HRPC tissue.
- Hormonal stimulation significantly influences the expression of RAS components in prostate cancer.
- These findings suggest a potential role for prostatic RAS in prostate cancer progression, particularly in hormone-refractory cases.
More Related Videos
Related Concept Videos
Hormonal Regulation
Hormonal Regulation
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Types of Hormones
Types of Hormones
Steroids and eicosanoids fall under the category of lipid-soluble hormones. Steroids are derived from cholesterol and feature four interconnected carbon rings with variable side chains. Notable examples include estradiol from ovaries and testosterone from testes, exemplifying the critical roles of these lipid-soluble hormones in reproductive physiology. Eicosanoids, derived...
Plant Hormones

